| 产品描述: | Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great security in rat and dog. Fotagliptin benzoate can be used for Type 2 diabetes mellitus research. |
| 靶点: |
DPP-4:22.7 nM (IC50) |
| 体外研究: |
Fotagliptin benzoate (33 mg/kg 或 110 mg/kg) 在不同剂量下对大鼠和狗是安全的[1]。 |
| 体内研究: |
Fotagliptin benzoate (33 mg/kg 或 110 mg/kg) 在不同剂量下对大鼠和狗是安全的。 |
| 参考文献: |
1. Wang Z, et al. Development and validation of a UPLC-MS/MS method for simultaneous determination of fotagliptin and its two major metabolites in human plasma and urine. Bioanalysis. 2017 Feb;9(4):381-393. |
| 保存条件: |
-80°C 12个月; -20°C 6个月,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.153 ml |
10.764 ml |
21.529 ml |
| 5 mM |
0.431 ml |
2.153 ml |
4.306 ml |
| 10 mM |
0.215 ml |
1.076 ml |
2.153 ml |
| 50 mM |
0.043 ml |
0.215 ml |
0.431 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |